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A. CONTROL B. LIDOCAINE
Conclusion: Short cycles of ischemic preconditioning resulted in less
[Ca2+]i accumulation and improved hemodynamic recovery. Lidocaine pre-
treatment induced also calcium influx, mimicking the first episode of is-
chemic preconditioning.
Antiarrhythmic Drugs
Tuesday, March 21, 1995,4:00 p.m.-5:30 p.m.
Ernest N. Morial Convention Center, Room 26
72 to 576 ± 97 Vlsec (p = 0.04) and squared conduction velocity (0 2) from
1.28 ± 0.5 to 1.04 ± 0.4 (M/s)2. With K+ depolarization to Vm = -70 mV,
FLEC further reduced IImax from 324 ± 100 to 241 ± 64 VIs and 02 from
0.90 ± 0.3 to 0.83 ± 0.5 (M/s)2 and produced a 1.9 mV hyperpolarizing shift
of apparent Na+ channel availability curves derived from 02. The addition
of 1 JLM isoproterenol (ISO) to FLEC-superfused fibers at physiologic Vm in-
creased 02 by 10% to 1.14 ± 0.5 (M/s)2 (p = 0.009) without altering IImax . At
-70 mV, the addition of ISO magnified the FLEC-induced reduction of IImax
an additional 26% to 177 ± 49 VIs (p = 0.001) and 02 by 20% to 0.67 ±
0.4 (M/s)2 (p = 0.008), producing an additional 1.8 mV (p = 0.001) and 1.9
mV (p = 0.001) hyperpolarizing shift in the apparent Na + channel inactiva-
tion curves generated from IImax and 02, respectively. At physiologic Vm,
the action potential duration (APD95) was reduced from 308 ± 32 to 266 ±
25 (p < 0.001) by FLEC and subsequently to 217 ± 4 (p < 0.001) with ISO
addition. With 12 mM K+, APD95 decreased from 193 ± 24 to 179 ± 20 ms
(p = 0.001) with FLEC and to 162 ± 14 ms (p = 0.001) with ISO. Thus. at
depolarized Vm• ISO amplified the FLEC-induced reduction of IImax and 02 ,
suggesting a further adrenergic-mediated reduction of Na+ current. Conse-
quently, the synergy between catecholamines and FLEC at depolarized Vm
and the shortened APD95 could facilitate double-wave reentrant arrhythmias
in the presence of FLEC and superimposed ischemia.
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1771-1 I Role of Intracellular Calcium In the Antiarrhythmic
Effect of Procalnamide During Ventricular Fibrillation
In Rat Hearts
ka Ix 106) la kr (x 102) Ir
(mol-1 s-1) 15-1) (mol-1 5-1) (5-1)
CD 70 ± 2.6 12.0 ± 4.4 0.6 ± 1.7 4.01 ± 1.63
02 100 ± 3.4 147 ± 2.5 28 ± 5.7 3.66 ± 1.40
Vmax(prox) 6.8 ± 2.3 15.9 ± 5.0 5.1 ± 10.3 4.22 ± 1.11
Kevin 1. Cragun, Susan B. Johnson, Douglas L. Packer. Mayo Foundation. Rochester.
MN
To quantitatively characterize flecainide-induced channel blockade from use-
dependent conduction delay (CD). 12 canine purkinje fibers were studied
using a dual microelectrode technique. During 60 sec of pacing at interstim-
ulus intervals (151) of 1.25-0.4 sec with 2 JLM flecainide (FLEC), incremental
CD followed a monoexponential time course, the rates of which were lin-
early related to the interpulse recovery interval (tr = 151 - action potential
duration). Steady state block was an exponential function of the recovery
rates. Use-dependent block derived from incremental CD and decremental
squared conduction velocity (02 ) was characterized by the forward (k) and
reverse (I) rate constants for the activated (a) and resting (r) states:
These rates reflect marked open state Na+ channel block and closed chan-
nel trapping at resting membrane potentials with FLEC. The addition of 1 JLM
isoproterenol (ISO) to FLEC-superfused fibers reversed the FLEC-induced re-
duction of 02 from 1.79 ± 0.7 to 1.89 ± 0.89 (m/s)2 (p = 0.017) without
changing IImax . The rate constants for FLEC binding and unbinding were not
altered by ISO. Thus FLEe's apparent binding rates can be quantified from
its use-{jependent effects on conduction. Both ISO's selective reversal of
FLEC effect on 02 but not IImax and the absence of changes in the rate con-
stants suggest that the modulation of FLEC effect is due to an alteration in
passive membrane properties. These characterizations will facilitate subse-
quent comparisons of FLEC interactions in pathologic and hyperadrenergic
states in vivo.
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1771-31 Direct Characterization of F1ecalnide Binding Rates
from Use-Dependent Conduction Delay In Canine
Purkinje Fibers
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Christian E. Zaugg. Shao 1. Wu. Shoji Kojima. Joan Wikman-Coffelt, William
W. Parmley University of California San Francisco, San Francisco, CA
Intracellular calcium ([Ca2+]i) overload is considered one of the factors that
cause ventricular fibrillation (VF). In addition, VF itself causes and main-
tains [Ca2+]i overload. We tested whether the class IA antiarrhythmic agent
procainamide can reduce [Ca2+]i overload during VF and if so, whether
such reduction is responsible for the recovery of left ventricular function.
For this purpose, we measured the effects of 0.1 mM (0.03 mg/ml) pro-
cainamide perfusion on left ventricular developed pressure (LVP), heart rate,
and [Ca2+]i during pacing-induced VF in isolated rat hearts. [Ca2+]i was as-
sessed by surface fluorometry after Indo-1/AM-loading. The concentration
of procainamide was selected in a way that about half of the hearts would
recover from VF (criteria: recovery of LVP > 67%). During perfusion with 0.1
mM procainamide, 6 hearts recovered from VF (e), whereas 8 hearts did not
recover (., recovery of LVP < 33%). In the untreated control group (0, n =
5), no heart recovered from VE Procainamide effects on heart rate (left panel)
and [Ca2+]i (right panel) are shown (mean ± SEM; t p < 0.05 vs. control; *p
< 0.05 vs. no recovery):
We conclude that procainamide can reduce [Ca2+]i overload during VE In
addition, the reduction of the [Ca2+ +]i overload might be responsible for the
recovery of the left ventricular function. This reduction appeared to be de-
pendent on the fibrillation rate (use-dependent) rather than on the decrease
of heart rate.
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Isoproterenol Amplification of Flecainide-induced
Conduction SlOWing In Depolarized Canine Purklnje
Fibers: Elucidation of Flecalnide Proarrhythmia in
CAST
Kevin T. Cragun, Susan B. Johnson, Douglas L. Packer. Mayo Foundation, Rochester.
MN
To elucidate the potential mechanism for the flecainide (FLEC) proarrhyth-
mia observed in CAST, the voltage-dependence of p-adrenergic modulation
of impulse propagation in 10 FLEC-superfused canine Purkinje fibers was
examined using a dual microelectrode technique. At physiologic membrane
potentials (Vm) ([K+Jo = 5.4 mM), 1 JLM FLEC decreased IImax from 677 ±
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Enhancement of Delayed Afterdepolarlzatlons
(DADs) and Triggered Activity by E·4031 and
Dofetlllde In a Cardiac Glycoside Model of Cell Ca2+
Overload
Jing 1. Xie, Peter M. Cunningham, Craig T. January University of Chicago. Chicago. IL
Hypothesis: Several new class III antiarrhythmic drugs, including E-4031 and
Dofetilide. are reported to selectively block the rapidly activating delayed
rectifier current (iKR). These drugs increase action potential duration (APD)
which should load cells with Ca2+ via the Na-Ca exchange mechanism and
Ca2+ channels. Thus DADs, which occur in Ca2+ loaded cells, should be
enhanced by these drugs. Methods: Action potentials were recorded from
sheep Purkinje fibers at pacing cycle lengths (CL) of 990 and 690 ms. Ca2+
overload with DADs were induced by exposing fibers to acetylstrophanthidin
(AS, 0.15 JLM) for 30 min. Fibers were then exposed to AS-free Tyrode's con-
taining E-4031 (E, 5.0 JLM; Group 1, n = 5), or Dofetilide (0,0.5 JLM; Group
2, n = 5), or no drug (Group 3, n = 5) for 30 min. Results: 1) Both E and 0 en-
hanced DAD amplitude. With AS exposure for 30 min. mean DAD amplitude
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dilated CMP(APD95)
can. 10-4 M 10-3 M
Intramural Heparin (ug)
3.70 ± 3.69
0.57 ± 0.82
0.13 ± 0.16
0.02 ± 001
Time of Harvest
Immediate
30 minutes
60 minutes
24 hours
ischemic CMP (APD95)
can. 10-4 M 10-3 M
Endo
0.5 HZ 304 ± 18 425 ± 26' 559 ± 23' 297 ± 17 390 ± 20' 457 ± 21'
1.0 HZ 274 ± 17 392 ± 18' 519 ± 27* 255 ± 21 383 ± 19' 405 ± 22'
Epi
0.5 HZ 280 ± 14 368 ± 19' 471 ± 20' 277 ± 17 371 ± 18' 419 ± 23'
10 HZ 250 ± 16 350 ± 20' 435 ± 18' 240 ± 13 367 ± 15' 388 ± 15'
Number of Vessels
4
4
4
4
'p < 0.05 Can. vs. d-Sot
Conclusion: D-Sotalol exhibits highly selective class-III activity under all
studied conditions. The parameters of repolarization were differentially af-
fected in the epicardial and endocardial structures with a maximum effect in
the CAD endocardium. The heterogeneity of the endolepi repolarization pat-
terns was markedly more pronounced in ischemic than in dilated cardiomy-
opathy implying enhanced antiarrhythmic as well as proarrhythmic potential
in chronic ischemic myocardium.
Conclusions: Heparin can be safely delivered to coronary angioplasty sites
using iontophoresis. Although subsequent drug washout occurs rapidly,
small amounts of intramural heparin delivered with this technique persist
for at least 24 hours.
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Local Intracoronary Delivery of Heparin and of a
Somatostatin Analogue (Octreotide) Following
Angioplasty in Man: Evaluation of Efficacy of Delivery
by Radio-Isotopic Technique
Local Intracoronary Delivery
In 37 patients (28 men, 58 ± 10 years) following conventional PTCA heparin
(H) (n = 37) and Octreotide (0) (n = 10) was infused through the Dispatch '"
(Scimed) at the site of angioplasty. Mean drug infusion time was 30 ± 7 min
(range: 7-39 min). Avolume of 16 ± 6 ml (range: 1.4-23.4 mil corresponding
to 1660 ± 656 IU Hand 0.39 ± 0.02 I'-g 0 was infused with a mean pres-
sure of 110 ± 48 mmHg. Radio-isotopic studies with infusion of technetium
labelled H (Tc-99m H; n = 2) or of indium labelled 0 (In-111 0; n = 5) were
performed to assess efficacy of local drug delivery. During infusion a linear
Edoardo Camenzind, Ambroos Reys, Jurgen Ligthart, Willem Bakker, Inge van
GeiJlswijk, Paolo Fioretti, Eric Krenning, Patrick W. Serruys. Departments
Thoraxcentre, Nuclear Medicine and Pharmacy, Erasmus University, Rotterdam,
Netherlands
1772-11 Localized Intracoronary Delivery of Heparin with
Iontophoresis
Joseph F. Mitchel, Michael A. Azrin, Daniel B. Fram, Hamid Feroze, Adel M. Eldin,
Michael Shwedick, David D. Waters, Raymond G. McKay. Hartford Hospital,
University of Connecticut, Hartford, cr
Previous work by our laboratory has demonstrated successful local deliv-
ery of heparin at angioplasty sites with a novel iontophoresis catheter which
uses an applied electric field to selectively move charged drug molecules
into the arterial wall. In order to assess the safety and efficiency of this
technique in the local delivery of heparin in the coronary vasculature, ion-
tophoresis of 3H-heparin was performed in 16 coronary arteries in 7 anes-
thetized pigs. All vessels initially underwent conventional balloon angioplasty
for 60 seconds at 6 atm using standard angioplasty catheters with a balloon-
artery ratio of 1.1 :1. Iontophoresis at 5 mA was then performed with a similar
sized catheter using a heparin concentration of 1000 U/ml, an iontophoretic
membrane balloon pressure of 1 atm, and an iontophoresis time of 90 secs.
Vessels were subsequently harvested at various times up to 24 hours and
counted in a scintillation counter to quantitate intramural heparin deposition
and wash-out.
Results: Heparin iontophoresis in all16 vessels was well tolerated without
change in systemic blood pressure, cardiac rhythm, or coronary angiography.
Intramural drug levels are listed below:
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Heterogenous Repolarization Parameters in Human
Endo- and Epicardial Tissue After Application of
Class-III Agent d-Sotalol in Ischemic and Dilated
Cardiomypathy
Harald Marschang, Thorsten Beyer, Maria Montero, Wolfgang Kubler,
Johannes Brachmann. Department of Cardiology, University of Heidelberg, Germany
Proarrhythmic effects are known as the major limiting factors of antiarrhyth-
mic drug therapy. In class-III compounds proarrhythmia mostly manifests as
Torsade de pointes tachyarrhythmia correlated with EADs and other non-
specific ventricular arrhythmias. The precise underlying mechanism of this
phenomenon and its possible modulation in different pathologic conditions
is still unclear. Intracellular action potentials were recorded by standard mi-
croelectrode techniques from the endo- and epicardial surface of human
myocardial specimens obtained from explanted hearts of patients with is-
chemic and dilated cardiomyopathy undergoing orthotopic heart transplant.
The following electrophysiological parameters were registered: AP ampli-
tude (APA), resting membrane potential (RMP), AP duration at 95% and 50%
repolarization (APD 95 and 50), maximal upstroke velocity (Vmax ) and effec-
tive refractory period (ERP). Values are expressed as mean ± SO.
William J. Groh, James G. Maylie Oregon Health Sciences University, Portland, OR
Myocardial stretch has been shown to shorten action potential duration
(APD) and thus may modulate the efficacy of class III antiarrhythmic agents.
We studied the effect of hypotonic-induced stretch on guinea pig ventricu-
lar myocytes treated with the d-sotalol analogue, E-4031, using a whole-cell
patch clamp technique.
Methods: Myocytes were perfused with normal Tyrode solution [300
mOsmollil at 23°C and dialyzed with a pipette containing (mM): K-Asp 90,
KCI40, NaCI10, MgCI2 1, MgATP 5, HEPES 10, EGTA 10, CaCI2 1, pH 7.1
[310 mOsmolll].
Results: Addition of 10 ILM E-4031 prolonged the APD by 10.1 ± 1.8%
(mean ± SEM), n = 10, P < 0.001. Perfusion with hypotonic (hT) solution [Ty-
rode less 35 mM NaCl, 230 mOsmolli1 + 10 ILM E-4031 induced cell swelling
with width increasing by 38.7 ± 2.7% and length by 6.0 ± 0.7 measured at 5
min, n = 36, p < 0.001. The APD measured at 5 min shortened in hT solution
by 38.7 ± 2.7%, n = 10, p < 0.001. Voltage-clamp studies showed no sig-
nificant change in the Na+, Ca2+, or inward rectifier K+ currents. The slow
component of the delayed rectifier K+ current (lKs) measured during a 5 s de-
polarization to 60 mV increased in hT solution by 31.4 ± 8.2% from 8.2 ± 1.1
pNpF to 10.4 ± 2.5 pNpF, n = 10, P < 0.001. Addition of 10 ILM azimilide
(NE-10064), a potent blocker of IKs ' inhibited the time-dependent outward
current at 60 mV by 82.0 ± 5.3%, n = 10, p = 0.002. The initial current at 60
mV was increased in hT solution by 4.1 ± 2.2 pNpF. This initial current was
partially inhibited by the CI- channel blocker, DIDS, and was not effected by
10 ILM azimilide. In CI--free hT solutions, IKs increased to a similar degree
as in CI--containing solutions (46.8 ± 16.8%, n = 4, p = 0.05). No increase
in the initial current was observed in CI- -free hT solutions.
Conclusions: Hypotonic-induced stretch upregulates IKs and a CI- current
and underlies the APD shortening which occurs with stretch. The increase
in these repolarizing currents with stretch antagonizes the APD prolonging
effect of the d-sotalol analogue, E-4031.
reached 5.6 ± 1.3 and 4.4 ± 0.7 mV for Groups 1-2, respectively (CL 990
ms). After 10 min exposure to E or 0, DAD amplitude increased to 6.6 ± 1.3
and 6.5 ± 1.0 mY, respectively (p < 0.05). In Group 3, after switching from
AS to no drug for 10 min, DAD amplitude was decreased by 2.2 ± 0.5 mV (p
< 0.05). Similar findings were obtained at the 690 ms CL. 2) E and 0 exerted
a biphasic effect on APD, initially shortening it at 10 min of exposure (p <
0.05) before it lengthened. 3) E and 0 prolonged DAD disappearance time
(36.0 ± 2.4, 34.0 ± 8.7, and 16.0 ± 2.4 min in Groups 1-3, respectively). 4)
E and 0 occasionally induced triggered action potentials. Lowering [K]o (5.4
to 4.0 mM) worsened these effects. 5) Without prior AS exposure, E caused
only prolongation of APD and occasionally the induction of early afterdepo-
larizations. Conclusions: E and 0 enhanced DADs and triggered activity. In
the presence of AS induced Ca2+ overload, E and 0 caused shortening of
APD. These effects can not be explained solely by selective block of iKR by E
and D. Additional drug effects, resembling enhancement of cardiac glycoside
toxicity, exist.
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1771-51 Stretch Antagonizes the Action Potential Prolonging
Effect of a Class III Antiarrhythmic Agent: Mechanism
of Action
